Latest Whitepapers

Partnering with experienced antibody developers can streamline cell line development, optimize production and accelerate your in vitro diagnostics (IVD) launch without compromising quality.

This whitepaper explores best practices for selecting and managing contract manufacturing organization (CMO) partnerships, focusing on in vitro diagnostics (IVD) development and critical raw materials. It highlights strategies to streamline approval

This whitepaper provides a roadmap for leveraging advanced proteomics platforms to identify biomarkers capable of detecting disease at its earliest stages.

This whitepaper shows how an industrialized MS platform delivers <5% median precision across protein groups and sustained reproducibility for FDA-approved biomarkers over nearly a year of plasma analysis.

This article explores how NGS-based proteomics addresses these challenges, highlights recent advancements in the field and examines its impact on multiomics research and precision medicine.

This whitepaper explores a novel blood collection tube (research use only) that provides extended plasma protein stability, limits preanalytical variability and supports high-quality data generation across multiple proteomic platforms.

This whitepaper explores comprehensive strategies for overcoming workflow limitations while maximizing sensitivity in next-generation sequencing (NGS) applications.

This whitepaper explores the emerging role of molecular genotyping in improving the accuracy of extended and rare blood type identification, reducing the risks of adverse reactions and supporting critical transfusion needs.

This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.

This whitepaper provides a comprehensive framework to guide this critical decision, examining cost, expertise and time-to-market.